Angela Bhatt

Angela Bhatt investigates the role of gabapentinoids in cancer pain management, studying how gabapentin and pregabalin modulate central sensitization and neuropathic pain components of cancer pain through alpha-2-delta calcium channel subunit binding. Her clinical research has evaluated gabapentinoid efficacy in chemotherapy-induced peripheral neuropathy and bone cancer pain. She has contributed to evidence-based guidelines for multimodal cancer pain management. Her translational work bridges pain neuroscience with practical oncology pain management.